320 related articles for article (PubMed ID: 8188535)
1. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
[TBL] [Abstract][Full Text] [Related]
2. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
3. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
[TBL] [Abstract][Full Text] [Related]
7. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
Erb K; Pechstein B; Schueler A; Engel J; Hermann R
Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
[TBL] [Abstract][Full Text] [Related]
8. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
9. Comparative response of rams and bulls to long-term treatment with gonadotropin-releasing hormone analogs.
Jiménez-Severiano H; D'Occhio MJ; Lunstra DD; Mussard ML; Davis TL; Enright WJ; Kinder JE
Anim Reprod Sci; 2007 Apr; 98(3-4):204-24. PubMed ID: 16616998
[TBL] [Abstract][Full Text] [Related]
10. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
[TBL] [Abstract][Full Text] [Related]
11. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
[TBL] [Abstract][Full Text] [Related]
12. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
[TBL] [Abstract][Full Text] [Related]
13. Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.
Jockenhövel F; Bhasin S; Steiner BS; Rivier JE; Vale WW; Swerdloff RS
J Clin Endocrinol Metab; 1988 May; 66(5):1065-70. PubMed ID: 3129447
[TBL] [Abstract][Full Text] [Related]
14. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
[TBL] [Abstract][Full Text] [Related]
15. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin releasing hormone (GnRH) agonists in male contraception.
Swerdloff RS; Steiner BS; Bhasin S
Med Biol; 1986; 63(5-6):218-24. PubMed ID: 2939304
[TBL] [Abstract][Full Text] [Related]
17. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men.
Behre HM; Kliesch S; Pühse G; Reissmann T; Nieschlag E
J Clin Endocrinol Metab; 1997 May; 82(5):1403-8. PubMed ID: 9141524
[TBL] [Abstract][Full Text] [Related]
18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
19. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
20. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
